Disease Management

Dáil Éireann Debate, Wednesday - 25 March 2026

• Debates
• Find a debate
  • Dáil debates
  • Seanad debates
  • Committee debates
• Find a vote
  • Dáil votes
  • Seanad votes
  • Committee votes
• Parliamentary questions
  • Written questions
  • Oral questions
• Search tips
• Utterances having an adverse effect

Wednesday, 25 March 2026

Questions (355, 356)

Grace Boland

Question:

355. Deputy Grace Boland asked the Minister for Health the steps her Department and the HSE are taking to address issues relating to barriers currently faced by patients in Ireland living with lipoedema, including the absence of a published national HSE care pathway, limited access to conservative management such as compression therapy and manual lymphatic drainage, and delays or difficulties accessing treatment through the Cross Border Healthcare Directive; and if she will make a statement on the matter. [22641/26]

Grace Boland

Question:

356. Deputy Grace Boland asked the Minister for Health if the HSE working group established in 2023 to develop a national care pathway for lipoedema has completed its work; when the pathway is expected to be published; whether patient advocacy organisations (details supplied), will participate in the development and implementation of this pathway; and if she will make a statement on the matter. [22642/26]

Written answers

Minister for Health

I propose to take Questions Nos. 355 and 356 together.

As the matter(s) raised is a service delivery matter, I have asked the Health Service Executive to respond to the Deputy directly as soon as possible.

Question No. 356 answered with Question No. 355.

• Previous Answer
• Next Answer